Skip to main content
. 2013 Dec 13;5(1):64–70. doi: 10.4161/gmic.27128

Table 1. Active bacterial composition based on 16S rRNA analyses in the follow-up study.

  Relative percentage of active bacteria (%)
FS-0 FS-3 FS-6 FS-11 FS-14 FS-40
Blautia (Firmicutes) 27.84 3.13 0.51 0.14 0 14.02
Gemmiger (Betaproteobacteria) 4.44 0.06 0 0.05 0 0.70
Uncl. Actinobacteria 2.21 0.40 0 0.00 0.05 0.15
Enterococcus (Firmicutes) 0 14.56 0.51 0.42 0.05 0.00
Uncl. Bacteroidetes 3.99 13.37 11.34 4.66 4.44 3.68
Bifidobacterium (Actinobacteria) 1.44 4.38 0.13 0 0.02 0.73
Uncl. Firmicutes 1.42 2.10 10.57 2.68 0.52 2.34
Akkermansia (Verrucomicrobia) 0.53 0 6.62 1.98 0 0
Alistipes (Bacteroidetes) 0 0.63 4.20 2.59 0.52 0.58
Parabacteroides (Bacteroidetes) 1.49 4.84 4.33 17.36 7.94 2.51
Bacteroides (Bacteroidetes) 23.15 24.74 10.83 36.12 74.24 20.98
Faecalibacterium (Firmicutes) 1.37 0 0.51 1.32 0.07 11.35
Uncl. Ruminococcaceae (Firmicutes) (Firmicutes) 0.82 0.17 3.06 2.30 0.17 9.69
Ruminococcus (Firmicutes) 0.03 0 0 0 0 6.59

Samples FS-0, FS-3, FS-6, FS-11, and FS-14 correspond to the materials collected on days 0, 3, 6, 11, and 14 of the antibiotic treatment, respectively. The FS-40 sample corresponds to the materials collected 40 days after cessation of the antibiotic treatment. Only bacteria with abundance level higher than 1% were included.